IMMR reported Q2 results with the decision to carry BNED at investment value instead of marking to market. This has distorted IMMR's true book value and contributed to the stock selling off
What is covered in the Full Insight:
Introduction
Second Quarter Results
Book Value Analysis
Patent Lawsuit Settlement
Investment in BNED
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.